×

GLP-1 formulations

  • US 6,358,924 B1
  • Filed: 06/01/2000
  • Issued: 03/19/2002
  • Est. Priority Date: 12/05/1997
  • Status: Expired due to Term
First Claim
Patent Images

1. A stable pharmaceutical formulation comprising a GLP-1 compound selected from the group consisting of:

  • GLP-1, GLP-1 analogs, and GLP-1 derivatives wherein the GLP-1 compound can bind to the GLP-1 receptor, complexed with an anionic surfactant selected from the group consisting of docusate sodium, docusate calcium, docusate potassium, sodium dodecyl sulfate, sodium caprylate, sodium cholate, sodium deoxycholate, sodium taurocholate, and sodium glycocholate and a preservative wherein the stable formulation is a solution and has a pH between about 6.5 and about 9.0.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×